Literature DB >> 22376107

Thrombin binding aptamer, more than a simple aptamer: chemically modified derivatives and biomedical applications.

Anna Avino1, Carme Fabrega, Maria Tintore, Ramon Eritja.   

Abstract

The thrombin binding aptamer (TBA) is a well characterized chair-like, antiparallel quadruplex structure that binds specifically to thrombin at nanomolar concentrations and therefore it has interesting anticoagulant properties. In this article we review the research involved in the development of new TBA derivatives with improved anticoagulant properties as well as the use of the TBA as a model compound for the study of quadruplex structures. Specifically, we describe the impact of modified nucleosides and non-natural backbones in the guanine tetrads or in the loops and the introduction of pendant groups at the 3' or 5'-ends. The modified oligonucleotides are shown to be excellent tools for the understanding of the molecular structure of the TBA and its folding properties. Finally, we review the use of the TBA-Thrombin recognition system for the development of analytical tools based on the TBA folding.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22376107     DOI: 10.2174/138161212799958387

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  31 in total

Review 1.  The Toolbox for Modified Aptamers.

Authors:  Sergey A Lapa; Alexander V Chudinov; Edward N Timofeev
Journal:  Mol Biotechnol       Date:  2016-02       Impact factor: 2.695

2.  Mapping the affinity landscape of Thrombin-binding aptamers on 2΄F-ANA/DNA chimeric G-Quadruplex microarrays.

Authors:  Jory Lietard; Hala Abou Assi; Irene Gómez-Pinto; Carlos González; Mark M Somoza; Masad J Damha
Journal:  Nucleic Acids Res       Date:  2017-02-28       Impact factor: 16.971

3.  Structural Characterization of a Thrombin-Aptamer Complex by High Resolution Native Top-Down Mass Spectrometry.

Authors:  Jiang Zhang; Rachel R Ogorzalek Loo; Joseph A Loo
Journal:  J Am Soc Mass Spectrom       Date:  2017-07-28       Impact factor: 3.109

Review 4.  In What Ways Do Synthetic Nucleotides and Natural Base Lesions Alter the Structural Stability of G-Quadruplex Nucleic Acids?

Authors:  Janos Sagi
Journal:  J Nucleic Acids       Date:  2017-10-18

5.  Crystal structures of thrombin in complex with chemically modified thrombin DNA aptamers reveal the origins of enhanced affinity.

Authors:  Rafal Dolot; Curtis H Lam; Malgorzata Sierant; Qiang Zhao; Feng-Wu Liu; Barbara Nawrot; Martin Egli; Xianbin Yang
Journal:  Nucleic Acids Res       Date:  2018-05-18       Impact factor: 16.971

6.  Polymer Microneedle Mediated Local Aptamer Delivery for Blocking the Function of Vascular Endothelial Growth Factor.

Authors:  James Coyne; Brandon Davis; David Kauffman; Nan Zhao; Yong Wang
Journal:  ACS Biomater Sci Eng       Date:  2017-10-31

Review 7.  RHAU Peptides Specific for Parallel G-Quadruplexes: Potential Applications in Chemical Biology.

Authors:  Le Tuan Anh Nguyen; Dung Thanh Dang
Journal:  Mol Biotechnol       Date:  2022-08-19       Impact factor: 2.860

8.  Anomeric DNA quadruplexes.

Authors:  Natalia A Kolganova; Anna M Varizhuk; Roman A Novikov; Vladimir L Florentiev; Galina E Pozmogova; Olga F Borisova; Anna K Shchyolkina; Igor P Smirnov; Dmitry N Kaluzhny; Edward N Timofeev
Journal:  Artif DNA PNA XNA       Date:  2014

9.  Site-specific replacement of the thymine methyl group by fluorine in thrombin binding aptamer significantly improves structural stability and anticoagulant activity.

Authors:  Antonella Virgilio; Luigi Petraccone; Valentina Vellecco; Mariarosaria Bucci; Michela Varra; Carlo Irace; Rita Santamaria; Antonietta Pepe; Luciano Mayol; Veronica Esposito; Aldo Galeone
Journal:  Nucleic Acids Res       Date:  2015-11-17       Impact factor: 16.971

10.  Sugar-modified G-quadruplexes: effects of LNA-, 2'F-RNA- and 2'F-ANA-guanosine chemistries on G-quadruplex structure and stability.

Authors:  Zhe Li; Christopher Jacques Lech; Anh Tuân Phan
Journal:  Nucleic Acids Res       Date:  2013-12-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.